Master EUMDR 2017/745 | Clause-by-Clause Breakdown | Your Complete 10-Week Implementation Guide.

Medical Device Insights - Issue #29 March 22, 2026

Mar 22, 2026

Hi There, 👋

Exciting news! After completing our ISO 13485 and ISO 14971 series, you asked for more. Today, I’m launching a brand new 10-week series: EU MDR Mastery - Your Complete Guide to Medical Device Regulation Compliance.

If you sell or plan to sell medical devices in Europe, this series is essential.

`Why this series?`

EU MDR 2017/745 is mandatory for all medical devices sold in Europe. It’s the difference between market access and market exclusion, between CE marking and certification denial, between EU competitiveness.

📚 NEW SERIES: EU MDR Mastery

Your 10-week journey starts today:

📍 Issue #29 (Today): EU MDR Introduction & Overview
⬜ Issue #30: General Safety & Performance Requirements (Annex I)
⬜ Issue #31: Technical Documentation (Annex II & III)
⬜ Issue #32: Clinical Evaluation & PMCF
⬜ Issue #33: Conformity Assessment & Notified Bodies
⬜ Issue #34: UDI, Registration & EUDAMED
⬜ Issue #35: Economic Operators & Responsibilities
⬜ Issue #36: Post-Market Surveillance & Vigilance
⬜ Issue #37: Quality Management & Risk Management
⬜ Issue #38: Implementation Roadmap & Practical Guidance

📌 Why EU MDR Changes Everything

The stark reality:

On May 26, 2021, EU MDR (Regulation 2017/745) fully replaced the Medical Device Directive (MDD 93/42/EEC).

What this means:

MDD certificates are invalid (with a few exceptions).
ALL devices need MDR compliance.
Requirements are significantly stricter.
Notified Body capacity severely limited.
Timeline pressures are intense.

Companies are struggling:

30-40% longer approval times.
Higher costs (2-3x more than MDD).
Greater documentation requirements.
Enhanced clinical evidence needs.
Stricter surveillance obligations.

Bottom line: EU MDR is the most complex medical device regulation ever implemented.

🎯 What is EU MDR?

Full name:

Regulation (EU) 2017/745 on Medical Devices.

Purpose:

Ensure a high level of safety and health protection for patients, users, and others while supporting innovation.

Scope:

Medical devices (excluding IVDs - covered by IVDR).
Accessories for medical devices.
Devices incorporating medicinal substances.
Devices manufactured utilizing tissues/cells of human/animal origin.

Legal status:

REGULATION (not Directive)

Critical difference:

Directive (MDD): Each EU country implements the national law (variations possible).
Regulation (MDR): Directly applicable in ALL EU countries (uniform application).

Result: Same requirements across the entire EU market.

🎯 Why MDR Replaced MDD

The problems with MDD:

1. Inconsistent implementation

Different interpretations by countries.
Different Notified Body standards.
Market surveillance gaps.

2. Insufficient clinical evidence requirements

Equivalence is too easily claimed.
Limited clinical data needed.
Post-market surveillance is weak.

3. Transparency lacking

No central database.
Limited public information.
Difficult to track devices/incidents.

4. Serious incidents

PIP breast implants scandal.
Metal-on-metal hip implants.
Vaginal mesh complications.

These failures drove MDR creation.

What MDR aims to fix:

✓ Harmonized requirements across the EU.
✓ Stricter clinical evidence.
✓ Enhanced post-market surveillance.
✓ Greater transparency (EUDAMED).
✓ Strengthened Notified Body oversight.
✓ Clearer economic operator responsibilities.
✓ Better traceability (UDI).

🎯 Key Changes from MDD to MDR

1. Clinical Evidence Requirements

MDD:

Equivalence is widely accepted.
Limited clinical data are often sufficient.
Harmonized standards provided a presumption of conformity.

MDR:

Equivalence restricted (stricter criteria).
Clinical evaluation is much more robust.
Sufficient clinical evidence is mandatory.
Post-Market Clinical Follow-up (PMCF) required.
Standards help, but don’t guarantee conformity.

Impact: More clinical investigations, longer timelines, higher costs.

2. Classification Rules

MDD: 18 classification rules.

MDR: 22 classification rules (some devices reclassified higher).

Examples of reclassification:

Software as Medical Device → Often higher class
Devices with nanomaterials → Class III
Devices for the spinal column → Class III
Reusable surgical instruments → Class I (but sterile = Class IIa)

Impact: More devices require Notified Body involvement.

3. Person Responsible for Regulatory Compliance (PRRC)

MDD: No such requirement.

MDR: MANDATORY.

Requirements:

At least one person in the organization.
Possess requisite expertise (university degree + 1-4 years experience, depending on class).
Responsible for regulatory compliance.
Available to Notified Bodies and authorities.

Impact: Need qualified personnel, training, organizational structure.

4. Unique Device Identification (UDI)

MDD: No UDI requirement

MDR: UDI mandatory

Requirements:

UDI-DI (Device Identifier)
UDI-PI (Production Identifier - serial number, lot, etc.)
UDI on label and packaging
UDI in the EUDAMED database

Impact: Labeling changes, database management, supply chain tracking.

5. EUDAMED Database

MDD: No central database.

MDR: EUDAMED mandatory (European Database on Medical Devices).

Modules:

Actor registration (manufacturers, authorized reps, importers)
UDI and device registration
Notified Bodies and certificates
Clinical investigations
Vigilance and post-market surveillance
Market surveillance

Impact: New registration requirements, public transparency, and data management burden.

6. Economic Operators

MDD: The manufacturer focuses mainly.

MDR: Clear obligations for ALL operators.

Defined roles:

Manufacturer
Authorized Representative
Importer
Distributor

Impact: Supply chain responsibilities, compliance verification, documentation requirements.

7. Post-Market Surveillance

MDD: Basic requirements

MDR: Comprehensive system required

MDR Requirements:

Post-Market Surveillance (PMS) plan.
PMS report (annually for Class I, PSUR for higher classes).
Periodic Safety Update Report (PSUR).
Enhanced vigilance.
Trend reporting.

Impact: Resource-intensive, systematic data collection, regular reporting.

8. Notified Body Requirements

MDD: Varied Notified Body standards.

MDR: Stricter designation requirements.

MDR Changes:

More stringent competence requirements.
Joint assessments by the EU Commission.
Unannounced audits are mandatory.
Enhanced surveillance.

Result: Fewer designated Notified Bodies, capacity crunch, longer wait times.

🎯 Who Must Comply with EU MDR?

1. Manufacturers

Definition: A person with responsibility for design/manufacture, intending to make the device available under their name.

Includes:

EU-based manufacturers.
Non-EU manufacturers (through Authorized Rep).

Obligations:

Ensure design/manufacture complies with MDR.
Establish a quality management system.
Compile technical documentation.
Conduct a clinical evaluation.
Establish post-market surveillance.
Report incidents.
Register in EUDAMED.

2. Authorized Representatives

Definition: Natural/legal person established in the EU with a written mandate from the manufacturer.

Required when: Manufacturer NOT established in the EU.

Obligations:

Verify the EU Declaration of Conformity exists.
Keep technical documentation available.
Cooperate with authorities.
Register in EUDAMED.
Inform the manufacturer of complaints/incidents.

Note: Authorized Rep does NOT assume manufacturer’s obligations (manufacturer still responsible).

3. Importers

Definition: Natural/legal person established in the EU placing a device from a third country on the EU market.

Obligations:

Verify the manufacturer has an Authorized Rep.
Verify the device has CE marking.
Verify labeling in the EU language.
Keep a copy of the Declaration of Conformity.
Store devices properly.
Register in EUDAMED.
Cooperate with authorities.

4. Distributors

Definition: Natural/legal person in the supply chain (other than manufacturer/importer) making a device available on the market.

Obligations:

Verify the device has CE marking.
Verify documentation is present.
Verify storage/transport conditions are maintained.
Cooperate with authorities.
Register in EUDAMED (if applicable).

Note: If the distributor modifies the device, they become the manufacturer.

🎯 MDR Timeline - What Happened

Key dates:

May 25, 2017: EU MDR published.

May 26, 2017: MDR entered into force (3-year transition).

May 26, 2020: Original application date.

April 2020: COVID-19 pandemic → Application date postponed.

May 26, 2021: MDR fully applicable.

May 26, 2024: MDD certificates expired (with limited exceptions).

May 26, 2025: Last date for legacy devices under certain conditions.

May 26, 2028: Final deadline for the sell-off of legacy devices.

Current situation (March 2026):

MDR is fully in force.
MDD is no longer valid (except for grandfathered legacy devices).
All new certifications under MDR.
Transition period essentially complete.

🎯 Device Classification Under MDR

Classification importance:

Device class determines:

Conformity assessment route.
Clinical evidence requirements.
Notified Body involvement.
Documentation depth.
PMS/PSUR requirements.

Four classes:

Class I: Low risk

Examples: Bandages, examination gloves, walking sticks.
Self-certification (generally no Notified Body).
Exception: Class I sterile, measuring function, reusable surgical = Notified Body.

Class IIa: Low-medium risk

Examples: Dental fillings, hearing aids, blood bags.
Notified Body required.
Less stringent clinical evidence.

Class IIb: Medium-high risk

Examples: Ventilators, bone screws, infusion pumps.
Notified Body required.
More stringent clinical evidence.
PSUR required.

Class III: High risk

Examples: Heart valves, implantable defibrillators, breast implants.
Notified Body required (strictest scrutiny).
Most stringent clinical evidence.
Often requires clinical investigation.
PSUR required.

Classification rules:

MDR Annex VIII contains 22 rules based on:

Invasiveness
Duration of use
Body part affected
Active/non-active device
Incorporated substances
Software function

Important: Many devices reclassified HIGHER under MDR vs MDD.

🎯 Conformity Assessment Routes

Class I (non-sterile, non-measuring):

Route: Self-certification

The manufacturer prepares technical documentation.
Manufacturer issues EU Declaration of Conformity.
The manufacturer affixes the CE mark.

No Notified Body needed (but manufacturer bears full responsibility)

Class I (sterile, measuring, reusable surgical):

Route: Annex IX (QMS) or limited NB assessment

Notified Body assesses specific aspects.
The manufacturer handles the rest.
The manufacturer issues a declaration of Conformity.

Class IIa:

Routes available:

Annex IX (full QMS) + Annex X (Type examination), OR
Annex IX (full QMS) + Annex XI (Product conformity)

Notified Body assesses QMS and/or technical documentation

Class IIb:

Routes available:

Annex IX (full QMS) + Annex X (Type examination), OR
Annex IX (full QMS) + Annex XI (Product conformity)

Notified Body is more thorough than IIa

Class III:

Routes available:

Annex IX (full QMS) + Annex X (Type examination), OR
Annex IX (full QMS) + Annex XI (Product conformity)

Notified Body, the most stringent assessment, consultation procedure with an expert panel for certain Class III devices.

🎯 The Challenges Companies Face

Challenge #1: Notified Body Capacity

Problem:

Fewer Notified Bodies designated under MDR.
Existing NBs are overwhelmed.
Wait times 12-24+ months.

Impact:

Delayed market access.
Cannot renew expiring certificates.
Competitive disadvantage.

What to do:

Engage NB early (18-24 months before needed).
Maintain a strong relationship with the current NB.
Prepare documentation thoroughly upfront.

Challenge #2: Clinical Evidence

Problem:

MDR requires robust clinical evidence.
Equivalence claims are harder to justify.
More clinical investigations are needed.
Retrospective studies inadequate.

Impact:

Higher costs.
Longer timelines.
Need clinical expertise.
Ethical and regulatory hurdles.

What to do:

Start clinical evaluation early.
Consider PMCF as an alternative/supplement.
Invest in clinical resources.
Plan clinical investigations if needed.

Challenge #3: Documentation Burden

Problem:

The technical documentation is much more extensive.
Clinical evaluation reports are more detailed.
PMS plans and reports are required.
EUDAMED registration.

Impact:

Resource-intensive.
Need specialized personnel.
Ongoing maintenance burden.

What to do:

Start documentation early
Hire/train qualified personnel (PRRC)
Use templates and systems
Integrate with QMS

Challenge #4: Post-Market Surveillance

Problem:

PMS must be systematic and comprehensive.
PSURs required for IIb and III
Vigilance reporting is more stringent.
Trend reporting is a new requirement.

Impact:

Resource requirements
Need data systems
Ongoing effort (not one-time)

What to do:

Establish a robust PMS system.
Integrate with complaint handling.
Automate where possible.
Allocate dedicated resources.

🎯 Benefits of MDR (Yes, There Are Some!)

1. Harmonized market

Same requirements across the EU.
Easier multi-country access.
Reduced national variations.

2. Improved safety

More rigorous clinical evidence.
Better post-market surveillance.
Enhanced traceability.

3. Greater transparency

EUDAMED public access.
Better-informed healthcare professionals.
Patient awareness.

4. Competitive advantage

High compliance bar favors quality manufacturers.
Barrier to entry for low-quality devices.
Reputation enhancement.

✅ Quick Self-Assessment

Answer honestly:

Do you sell or plan to sell devices in EU?
Is your organization familiar with MDR requirements?
Do you have a designated PRRC?
Is your technical documentation MDR-compliant?
Do you have robust clinical evidence?
Is your PMS system comprehensive?
Are you registered in EUDAMED?
Is your QMS MDR-compliant?
Do you have Notified Body engaged (if needed)?
Are you prepared for unannounced audits?

Less than 7 “yes” answers? This series is critical for you.

7-10 “yes” answers? This series will enhance your expertise.

📊 Series Tracker

📍 Issue #29: EU MDR Introduction & Overview (Today!)
⬜ Issue #30: General Safety & Performance Requirements
⬜ Issue #31: Technical Documentation
⬜ Issue #32: Clinical Evaluation & PMCF
⬜ Issue #33: Conformity Assessment & Notified Bodies
⬜ Issue #34: UDI, Registration & EUDAMED
⬜ Issue #35: Economic Operators & Responsibilities
⬜ Issue #36: Post-Market Surveillance & Vigilance
⬜ Issue #37: Quality Management & Risk Management
⬜ Issue #38: Implementation Roadmap